Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bryan A. Laffitte
Observed names:
B. Laffitte,
Bryan A Laffitte,
Bryan Laffitte,
Bryan, Laffitte,
Laffitte, Bryan
Institution:
Genomics Institute of the Novartis Research Foundation
Observed institutions:
Genomics Institute of the Novartis Research Foundation,
Howard Hughes Medical Institute,
University of California, Los Angeles,
University of California San Diego,
GlaxoSmithKline (United States),
The University of Texas Southwestern Medical Center
show all 6
OpenAlex ID:
A5048810295
A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
2001
·
Ajay Chawla
, William A. Boisvert
, et al.
·
Molecular Cell
·
1,345
PDF
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
2003
·
Sean B. Joseph
, Antonio Castrillo
, et al.
·
Nature Medicine
·
1,156
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
2000
·
Asha Venkateswaran
, Bryan A. Laffitte
, et al.
·
Proceedings of the National Academy of Sciences
·
1,004
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
2002
·
Sean B. Joseph
, Elaine McKilligin
, et al.
·
Proceedings of the National Academy of Sciences
·
947
Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors
2002
·
Sean B. Joseph
, Bryan A. Laffitte
, et al.
·
Journal of Biological Chemistry
·
780
LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes
2001
·
Bryan A. Laffitte
, Joyce J. Repa
, et al.
·
Proceedings of the National Academy of Sciences
·
683
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue
2003
·
Bryan A. Laffitte
, Lily C. Chao
, et al.
·
Proceedings of the National Academy of Sciences
·
502
Identification of macrophage liver X receptors as inhibitors of atherosclerosis
2002
·
Rajendra K. Tangirala
, Eric D. Bischoff
, et al.
·
Proceedings of the National Academy of Sciences
·
438
Farnesoid X-Activated Receptor Induces Apolipoprotein C-II Transcription: a Molecular Mechanism Linking Plasma Triglyceride Levels to Bile Acids
2001
·
Heidi Rachelle Kast
, Catherine M. Nguyen
, et al.
·
Molecular Endocrinology
·
336
PDF
Autoregulation of the Human Liver X Receptor α Promoter
2001
·
Bryan A. Laffitte
, Sean B. Joseph
, et al.
·
Molecular and Cellular Biology
·
315
GPR68 Senses Flow and Is Essential for Vascular Physiology
2018
·
Jie Xu
, Jayanti Mathur
, et al.
·
Cell
·
312
PDF
Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor
2000
·
Bryan A. Laffitte
, Heidi Rachelle Kast
, et al.
·
Journal of Biological Chemistry
·
275
PDF
Regulated Expression of the Apolipoprotein E/C-I/C-IV/C-II Gene Cluster in Murine and Human Macrophages
2002
·
Puiying A. Mak
, Bryan A. Laffitte
, et al.
·
Journal of Biological Chemistry
·
244
PDF
Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)
2017
·
David C. Tully
, Paul V. Rucker
, et al.
·
Journal of Medicinal Chemistry
·
237
PDF
Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
2015
·
Weijun Shen
, Brandon Taylor
, et al.
·
Nature Communications
·
203
PDF
The Phospholipid Transfer Protein Gene Is a Liver X Receptor Target Expressed by Macrophages in Atherosclerotic Lesions
2003
·
Bryan A. Laffitte
, Sean B. Joseph
, et al.
·
Molecular and Cellular Biology
·
163
Liver X receptors are regulators of adipocyte gene expression but not differentiation
2004
·
Sarah Hummasti
, Bryan A. Laffitte
, et al.
·
Journal of Lipid Research
·
120
Screening the mammalian extracellular proteome for regulators of embryonic human stem cell pluripotency
2010
·
Rodolfo Gonzalez
, Lori L. Jennings
, et al.
·
Proceedings of the National Academy of Sciences
·
104
Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis
2020
·
Donatella Chianelli
, Paul V. Rucker
, et al.
·
Journal of Medicinal Chemistry
·
103
PDF
Small-Molecule Inducer of β Cell Proliferation Identified by High-Throughput Screening
2013
·
Weijun Shen
, Matthew S. Tremblay
, et al.
·
Journal of the American Chemical Society
·
97
Tropifexor‐Mediated Abrogation of Steatohepatitis and Fibrosis Is Associated With the Antioxidative Gene Expression Profile in Rodents
2019
·
Eloy D. Hernandez
, Lianxing Zheng
, et al.
·
Hepatology Communications
·
95
PDF
Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth
2013
·
Jinyun Chen
, Franklin Chung
, et al.
·
Oncotarget
·
82
PDF
Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133
2020
·
Yahu A. Liu
, Qihui Jin
, et al.
·
Journal of Medicinal Chemistry
·
77
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Non–Bile Acid FXR Agonist Tropifexor (LJN452) in Healthy Volunteers
2019
·
Michael K. Badman
, Jin Chen
, et al.
·
Clinical Pharmacology in Drug Development
·
75
PDF
Transcription of the Vascular Endothelial Growth Factor Gene in Macrophages Is Regulated by Liver X Receptors
2004
·
Robert Walczak
, Sean B. Joseph
, et al.
·
Journal of Biological Chemistry
·
71
Show more works
View as search
Works count:
52
Citation count:
10,120
H-index:
30
I10-index:
34
Year
Topic
Type